Webinars and Sponsored Roundtables — Register Now
Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology,
Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Beckman Coulter
| Company | Beckman Coulter |
|---|---|
| Name of urinalysis instrument | DxU Microscopy Series: DxU 850m Iris, DxU 840m Iris |
| Contact | Kanochia Johnson |
| City, State | Brea, CA |
| Website | |
| Type of instrument | microscopy/sediment |
| Instrument list price | — (available via purchase or lease) |
| First year instrument sold in the U.S. | 2021 (also sold by McKesson, Henry Schein in U.S.) |
| Approximate No. of units in clinical use in the U.S./outside the U.S. | >800/>150 (worldwide) |
| Foreign countries where company markets instrument | worldwide |
| Country where instrument is designed/manufactured | U.S./U.S. |
| Human languages (other than English) supported | French, German, Spanish, Portuguese, Italian, many more |
| Intended urine sample volume per day | 50–600+ |
| Dimensions (H×W×D) | 23 × 21 × 25 in. |
| Weight fully loaded with reagents/without reagents | 100 lbs./85 lbs. |
| Power requirements | 100–240 VAC (50–60 Hz) |
| Mean time between failure of instrument | 305 days |
| Events that cause instrument to lock or stop analysis | QC failure, short sample, barcode/sample ID misread, result error, sampling error, consumables replacement/expiration |
| • Urine chemistry tests available on instrument in the U.S. | — |
| • Color compensation pad included/Flagging thresholds customizable | — |
| • Test strip configuration | — |
| • Calibration required after each test strip lot No. change | — |
| • Frequency of customer-performed calibration/Form of calibration | — |
| • How results are displayed for urine chemistry | — |
| • Specific gravity correction for protein/glucose | — |
| • Microscopy/sediment technology | digital flow morphology using auto particle-recognition software |
| • Microscopy/sediment analysis parameters | qualitative and quantitative: pathological casts, crystals, yeast-like cells, mucus, sperm, RBCs, WBCs, epithelial cells, bacteria, hyaline casts, WBC clumps |
| • Flagging thresholds customizable | yes |
| • Instrument eliminates amorphous crystal interference before sample analysis | no |
| • How results are displayed for microscopy/sediment | numeric values |
| • Reporting format customizable | yes |
| • No. of results that can be held in internal memory | 10,000 sample results/200 control results |
| Reagent shelf life/storage temp. for unopened containers of calibrator | 240 days/2–8°C |
| Reagent shelf life/storage temp. for opened containers of calibrator | 1 day/2–8°C |
| Reagent shelf life/storage temp. for unopened containers of control reagent | 240 days/2–8°C (focus and positive); 28°C (negative) |
| Reagent shelf life/storage temp. for opened containers of control reagent | 30 days/2–8°C |
| Reagent barcode-reading capability | yes, for some tests (can read Code 39, Code 128, more) |
| How often quality control samples are run | daily |
| Sample throughput per hour/Time to first result for chemistry | — |
| Sample throughput per hour/Time to first result for microscopy/sediment | DxU 840m: 70/<2 min.; DxU 850m: 101/<2 min. |
| Analyzer has stat mode | no (minimum sample volume for sampler or track mode, 3 mL) |
| FDA approved for body fluid analysis | yes (for CSF, pleural, peritoneal, synovial, more) |
| Sample dilutions required for urinalysis/body fluid analysis | no/yes (lyse reagent required) |
| Minimum width of sample tube/Minimum length of sample tube | 16 mm/100 mm |
| Conditions or substances that prevent a sample from being run | grossly visible turbidity |
| Means of sample ID entry | barcode scan, manual entry |
| Built-in liquid-level sensing for samples | yes |
| Information that can be barcode scanned on instrument | specimen identifier, reagent lot No., reagent expiration, dilution barcodes |
| Compatible with laboratory automation systems | no |
| How LOINC codes for results are made available | website |
| Software includes reflex testing/cross-check functionality | yes/no |
| Instrument automatically generates consolidated report* | yes |
| Instrument archives patient data | yes (up to 10,000 patient results) |
| Instrument connections to transfer information | directly to LIS |
| Interface standards or formats supported | ASTM 1381, ASTM 1238-95, Iris-defined XML |
| Bidirectional interface | yes, to other companies’ LISs |
| Test results can be transmitted to LIS as soon as tests completed | yes |
| Connection to LIS/EHR to upload patient and QC results | LIS: direct serial/EHR: — |
| Information included in transmission to data-management system | device unique identifier, operator ID, patient ID, specimen ID, result, QC identifier |
| Training included with instrument purchase | yes (1 day at customer site, 3 days of e-learning; follow-up training available for an extra charge) |
| Approximate scheduled maintenance time required | — (maintenance records kept onboard instrument) |
| Onboard diagnostics for troubleshooting | yes |
| Provide list of client sites to potential customers on request | yes (complete list with no restrictions regarding its use) |
| Clients restricted from sharing their experience with company or software | no |
| Distinguishing instrument features (supplied by company) | auto-classifies 12 urine particles based on size, shape, contrast, texture to provide digital images for all samples; iQ Body Fluids Module analyzes RBC count and nucleated cell count in cerebrospinal, synovial, and serous fluids |
| *chemistry and microscopy results in one report; Note: a dash in lieu of an answer means company did not answer; question or question is not applicable | †formerly iQ200 series; all answers apply to DxU 850m Iris and 840m Iris systems unless otherwise indicated |